Search - tctmd.com

Displaying 21 - 40 of 44

Sort: Relevancy | Date

News Daily News

Guidelines for Peripheral Interventions Often Built on Shaky Foundation

Caitlin E. Cox

January 10, 2019

News Conference News EuroPCR 2018

Two Sham-Controlled Renal Denervation Studies Offer Hope in Hypertension

Michael O'Riordan

May 23, 2018

News Industry News

Boehringer Ingelheim and Lilly announce an academic collaboration with University of Oxford to investigate the effects of Jardiance® in adults with chronic kidney disease

April 26, 2018

Presentation JIM 2018

Vascular Complications

Presenter: Bernhard Reimers

February 23, 2018

News Daily News

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

Shelley Wood

December 26, 2017

News Daily News

CKD Patients Undergoing PCI Much Less Likely to Receive Potent P2Y12 Inhibition

Michael O'Riordan

August 04, 2017

Presentation

Association Between CKD and Outcomes With Use of Prasugrel vs Clopidogrel in PCI for ACS

August 04, 2017

News Industry News

Armetheon Announces Positive Results of Pharmacokinetics Study of Tecarfarin versus Warfarin

August 25, 2016

News Daily News

New-Onset A-Fib, Chronic Kidney Disease Are Risk Factors For Stroke After TAVR, Meta-Analysis Shows

Yael L. Maxwell

August 10, 2016

News Industry News

FDA strengthens warning on NSAID labels

July 10, 2015

News Daily News

Method Chosen to Estimate Pre-PCI Kidney Function Matters

L.A. McKeown

June 29, 2015

News Daily News

Year in Review: Physicians Highlight the Most Important Interventional News of 2014

Todd Neale

January 12, 2015

News Daily News

Study Suggests Renal Denervation No More Effective Than Intensified Drug Treatment

Todd Neale

December 10, 2014

News Features

Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3

June 24, 2014

News Conference News AHA 2013

Long-term Outcomes with Renal Denervation Show Sustained Benefit

Yael L. Maxwell

November 16, 2013

Presentation TCT 2013

Expanding Clinical Indications: Moderate Hypertension and Replacing (vs. Supplementing) Medical Pharmacotherapy

Presenter: Krishna Rocha-Singh

October 30, 2013

News Daily News

Renal Denervation Lowers Ambulatory BP Measurements in Resistant Hypertension

June 28, 2013

News Daily News

La Dosis de Carga Doble de Clopidogrel No Ofrece Beneficio Alguno en Pacientes con ERC que se someten a PCI Primarias

L.A. McKeown

September 18, 2012

News Daily News

Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD

L.A. McKeown

September 18, 2012

News Conference News ACC 2012

Symplicity Works: Renal Denervation Reduces Resistant Hypertension

Yael L. Maxwell

March 27, 2012

Advertisement

Guidelines for Peripheral Interventions Often Built on Shaky Foundation

Two Sham-Controlled Renal Denervation Studies Offer Hope in Hypertension

Boehringer Ingelheim and Lilly announce an academic collaboration with University of Oxford to investigate the effects of Jardiance® in adults with chronic kidney disease

Vascular Complications

Year in Review: Physicians Pick the Biggest News of 2017, in Interventional Cardiology and Beyond

CKD Patients Undergoing PCI Much Less Likely to Receive Potent P2Y12 Inhibition

Association Between CKD and Outcomes With Use of Prasugrel vs Clopidogrel in PCI for ACS

Armetheon Announces Positive Results of Pharmacokinetics Study of Tecarfarin versus Warfarin

New-Onset A-Fib, Chronic Kidney Disease Are Risk Factors For Stroke After TAVR, Meta-Analysis Shows

FDA strengthens warning on NSAID labels

Method Chosen to Estimate Pre-PCI Kidney Function Matters

Year in Review: Physicians Highlight the Most Important Interventional News of 2014

Study Suggests Renal Denervation No More Effective Than Intensified Drug Treatment

Renal Denervation 2.0: Laying Out the Road to Recovery from Symplicity HTN-3

Long-term Outcomes with Renal Denervation Show Sustained Benefit

Expanding Clinical Indications: Moderate Hypertension and Replacing (vs. Supplementing) Medical Pharmacotherapy

Renal Denervation Lowers Ambulatory BP Measurements in Resistant Hypertension

La Dosis de Carga Doble de Clopidogrel No Ofrece Beneficio Alguno en Pacientes con ERC que se someten a PCI Primarias

Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD

Symplicity Works: Renal Denervation Reduces Resistant Hypertension

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content